腔内时代孤立性股总动脉内膜剥脱术的当代结局
单中心回顾性研究纳入2013–2023年96例患者共100例孤立性股总动脉内膜剥脱术,63%为慢性肢体威胁性缺血,68%为TASC A-B病变。围术期并发症以局部为主,再干预率18%,5年免于闭塞率86%;阿司匹林与术后闭塞风险降低独立相关。
要点
- 孤立性股总动脉内膜剥脱术早期局部并发症低、再干预可接受、远期通畅良好。
- TASC C-D病变闭塞率数值上高于A-B(12.5% vs 7.4%),但差异无统计学意义。
- 阿司匹林治疗与术后闭塞风险降低显著相关,支持其继续作为参考治疗。
核心结论
- 孤立性股总动脉内膜剥脱术治疗股总动脉闭塞性疾病安全耐久,早期局部并发症低、再干预率可接受、随访期免于闭塞率良好。
研究设计与样本
- 单中心回顾性观察研究,纳入2013年1月至2023年12月连续接受孤立性股总动脉内膜剥脱术的患者。
- 共96例患者、100例孤立性股总动脉内膜剥脱术;平均年龄68.5±9岁,男性89%,慢性肢体威胁性缺血63%。
- 病变按TASC II分类,TASC A-B占68%;中位随访3.5年(95%CI,3.2-3.9)。
- 采用Kaplan-Meier分析免于闭塞率,Cox回归探索术后闭塞相关因素,Fisher精确检验评估伤口闭合技术与止血辅助材料同术后并发症的关联。
主要发现
- 早期并发症以局部为主:腹股沟血肿4%、淋巴漏4%、淋巴囊肿5%、假性动脉瘤2%、感染8%。
- 18%的手术需再干预,其中开放再干预14%、腔内再干预4%;随访期间发生9例闭塞事件。
- 估计免于闭塞率:30天100%、1年96%、5年86%。
- TASC C-D病变闭塞率数值上高于TASC A-B(12.5% vs 7.4%;OR,1.80),但差异无统计学意义(p=0.462)。
- 单因素Cox回归中,阿司匹林治疗是唯一与术后闭塞风险降低显著相关的变量(HR,0.20;p=0.026)。
关键数值与推荐
- 病变按TASC II分类,TASC A-B占68%。
- TASC C-D与TASC A-B闭塞率比较:12.5% vs 7.4%(OR,1.80;p=0.462)。
- 阿司匹林与术后闭塞风险:HR,0.20(p=0.026)。
- 免于闭塞率:30天100%、1年96%、5年86%。
临床怎么用
- 孤立性股总动脉内膜剥脱术仍可作为股总动脉闭塞性疾病的参考治疗选择。
- 术后应关注腹股沟局部并发症(血肿、淋巴漏、淋巴囊肿、假性动脉瘤、感染)的监测与处理。
- 阿司匹林治疗与较低术后闭塞风险相关,围术期抗血小板管理值得重视。
- TASC C-D病变闭塞率数值较高但未达统计学显著,选择术式时仍需个体化评估。
局限性
- 单中心回顾性观察研究,样本量有限(96例患者、100例手术)。
- TASC C-D与A-B闭塞率差异未达统计学显著(p=0.462),相关比较效力不足。
- 阿司匹林与闭塞风险的关联仅来自单因素Cox回归,未报告多因素校正结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Common femoral endarterectomy remains the reference treatment for common femoral artery occlusive disease, yet contemporary real-world data focused specifically on isolated common femoral endarterectomy remain limited. This study aimed to evaluate the clinical profile, operative characteristics and outcomes of isolated common femoral endarterectomy performed in a tertiary vascular surgery center, with particular emphasis on postoperative complications, reintervention and occlusion, as well as the possible influence of wound closure technique and hemostatic adjunct use on local morbidity. METHODS: A retrospective observational study was conducted including consecutive patients who underwent isolated common femoral endarterectomy between January 2013 and December 2023. Baseline characteristics, clinical presentation, lesion complexity, operative details, postoperative complications, reinterventions and postoperative occlusion were analyzed. Lesions were classified according to TASC II. Kaplan-Meier analysis was used to assess freedom from occlusion, while Cox regression was performed to explore factors associated with postoperative occlusion. Fisher's exact test was used to assess associations between wound closure technique, hemostatic adjunct use and postoperative complications. RESULTS: A total of 96 patients underwent 100 isolated common femoral endarterectomies. Mean age was 68.5 ± 9 years, 89% were male and 63% presented with chronic limb-threatening ischemia. Most lesions were classified as TASC A-B (68%). Median follow-up was 3.5 years (95% CI, 3.2-3.9). Early postoperative complications were predominantly local, including groin hematoma (4%), lymphatic leakage (4%), lymphocele (5%), pseudoaneurysm (2%) and infection (8%). Overall, 18% of procedures required reintervention, with 14% undergoing open and 4% endovascular reintervention. Nine occlusive events occurred during follow-up. Estimated freedom from occlusion was 100% at 30 days, 96% at 1 year and 86% at 5 years. TASC C-D lesions showed a numerically higher occlusion rate than TASC A-B lesions (12.5% vs. 7.4%; OR, 1.80), although this difference was not statistically significant (p = 0.462). In univariable Cox regression, aspirin therapy was the only variable significantly associated with lower risk of postoperative occlusion (HR, 0.20; p = 0.026). Neither intradermal wound closure nor hemostatic adjunct use was significantly associated with postoperative complications. CONCLUSIONS: Isolated common femoral endarterectomy remains a safe and durable treatment for common femoral artery occlusive disease, with low rates of early local complications, acceptable reintervention rates and good freedom from occlusion during follow-up. These findings support the continued role of isolated common femoral endarterectomy as the reference treatment for common femoral artery disease in the endovascular era.
引用
- Cabral JM, Loureiro L, Guimarães CM, et al. Contemporary Outcomes of Isolated Common Femoral Endarterectomy in the Endovascular Era. Ann Vasc Surg. 2026. PMID: 42833576. doi:10.1016/j.avsg.2026.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。